RELMADA THERAPEUTICS, INC.·4

Jul 30, 5:11 PM ET

Vitolo Ottavio V. 4

4 · RELMADA THERAPEUTICS, INC. · Filed Jul 30, 2019

Insider Transaction Report

Form 4
Period: 2019-07-29
Vitolo Ottavio V.
Chief Medical Officer
Transactions
  • Award

    Options to purchase common stock

    2019-07-29$2.20/sh+150,000$330,000150,000 total
    Exercise: $2.20Exp: 2029-07-29Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.

Documents

1 file
  • 4
    ownership.xmlPrimary